Publication | Open Access

A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy

Surgical OncologyUrologyGenitourinary CancerMedicineCytoreductive NephrectomyImmune Checkpoint InhibitorCancer TreatmentMulticenter StudyOncologyRadiation OncologyNephrology